67 related articles for article (PubMed ID: 27434274)
1. Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists.
Mona CE; Besserer-Offroy É; Cabana J; Lefrançois M; Boulais PE; Lefebvre MR; Leduc R; Lavigne P; Heveker N; Marsault É; Escher E
J Med Chem; 2016 Aug; 59(16):7512-24. PubMed ID: 27434274
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of CXCR4 ligands.
Mona CE; Besserer-Offroy É; Cabana J; Leduc R; Lavigne P; Heveker N; Marsault É; Escher E
Org Biomol Chem; 2016 Nov; 14(43):10298-10311. PubMed ID: 27752700
[TBL] [Abstract][Full Text] [Related]
3. Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
Cutolo P; Basdevant N; Bernadat G; Bachelerie F; Ha-Duong T
J Biomol Struct Dyn; 2017 Feb; 35(2):399-412. PubMed ID: 26813575
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.
Mishra RK; Shum AK; Platanias LC; Miller RJ; Schiltz GE
Sci Rep; 2016 Jul; 6():30155. PubMed ID: 27456816
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists.
Evans BJ; Wang Z; Broach JR; Oishi S; Fujii N; Peiper SC
Methods Enzymol; 2009; 460():399-412. PubMed ID: 19446737
[TBL] [Abstract][Full Text] [Related]
6. Agonists for the Chemokine Receptor CXCR4.
Lefrançois M; Lefebvre MR; Saint-Onge G; Boulais PE; Lamothe S; Leduc R; Lavigne P; Heveker N; Escher E
ACS Med Chem Lett; 2011 Aug; 2(8):597-602. PubMed ID: 21841963
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
Xu L; Li Y; Sun H; Li D; Hou T
Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
[TBL] [Abstract][Full Text] [Related]
8. Bivalent 14-mer peptide ligands of CXCR4 with polyproline linkers with anti-chemotactic activity against Jurkat cells.
Tanaka T; Aoki T; Nomura W; Tamamura H
J Pept Sci; 2017 Jul; 23(7-8):574-580. PubMed ID: 28078743
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological characterization of novel PEG-linked dimeric modulators for CXCR4.
Yang Y; Gao M; Zhang Q; Zhang C; Yang X; Huang Z; An J
Bioorg Med Chem; 2016 Nov; 24(21):5393-5399. PubMed ID: 27658790
[TBL] [Abstract][Full Text] [Related]
10. High affinity CXCR4 inhibitors generated by linking low affinity peptides.
Zhang C; Huang LS; Zhu R; Meng Q; Zhu S; Xu Y; Zhang H; Fang X; Zhang X; Zhou J; Schooley RT; Yang X; Huang Z; An J
Eur J Med Chem; 2019 Jun; 172():174-185. PubMed ID: 30978562
[TBL] [Abstract][Full Text] [Related]
11. Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.
Trent JO; Wang ZX; Murray JL; Shao W; Tamamura H; Fujii N; Peiper SC
J Biol Chem; 2003 Nov; 278(47):47136-44. PubMed ID: 12958314
[TBL] [Abstract][Full Text] [Related]
12. Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies.
Costantini S; Raucci R; Colonna G; Mercurio FA; Trotta AM; Paola R; Leone M; Rossi F; Pellegrino C; Castello G; Scala S
J Pept Sci; 2014 Apr; 20(4):270-8. PubMed ID: 24474664
[TBL] [Abstract][Full Text] [Related]
13. Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection.
Chevigné A; Fievez V; Szpakowska M; Fischer A; Counson M; Plesséria JM; Schmit JC; Deroo S
Biochim Biophys Acta; 2014 May; 1843(5):1031-41. PubMed ID: 24480462
[TBL] [Abstract][Full Text] [Related]
14. Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression.
Nomura W; Koseki T; Ohashi N; Mizuguchi T; Tamamura H
Org Biomol Chem; 2015 Aug; 13(32):8734-9. PubMed ID: 26186480
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4.
Janz JM; Ren Y; Looby R; Kazmi MA; Sachdev P; Grunbeck A; Haggis L; Chinnapen D; Lin AY; Seibert C; McMurry T; Carlson KE; Muir TW; Hunt S; Sakmar TP
J Am Chem Soc; 2011 Oct; 133(40):15878-81. PubMed ID: 21905700
[TBL] [Abstract][Full Text] [Related]
16. Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636).
Zachariassen ZG; Karlshøj S; Haug BE; Rosenkilde MM; Våbenø J
J Med Chem; 2015 Oct; 58(20):8141-53. PubMed ID: 26397724
[TBL] [Abstract][Full Text] [Related]
17. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.
Di Prisco S; Olivero G; Merega E; Bonfiglio T; Marchi M; Pittaluga A
J Neuroimmune Pharmacol; 2016 Dec; 11(4):645-656. PubMed ID: 27147258
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor.
Huang X; Shen J; Cui M; Shen L; Luo X; Ling K; Pei G; Jiang H; Chen K
Biophys J; 2003 Jan; 84(1):171-84. PubMed ID: 12524273
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants of unexpected agonist activity in a retro-peptide analogue of the SDF-1alpha N-terminus.
Palladino P; Tizzano B; Pedone C; Ragone R; Rossi F; Saviano G; Tancredi T; Benedetti E
FEBS Lett; 2005 Oct; 579(24):5293-8. PubMed ID: 16182292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
